Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Plutzky

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Current Opinion in Lipidology|September 19, 2001
Peroxisome proliferator-activated receptors in endothelial cell biologyJ Plutzky
Current Opinion in Cardiology|February 24, 2001
Emerging concepts in metabolic abnormalities associated with coronary artery diseaseJ Plutzky
Current Atherosclerosis Reports|December 21, 2000
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigmsJ Plutzky
The American Journal of Cardiology|November 6, 2001
Inflammatory pathways in atherosclerosis and acute coronary syndromesJ Plutzky
The American Journal of Medicine|August 1, 1990
On being a physicianJ Plutzky
The American Journal of Cardiology|July 27, 1999
Atherosclerotic plaque rupture: emerging insights and opportunitiesJ Plutzky
Current Cardiology Reports|September 12, 2000
Effect of lipid-lowering therapy on vasomotion and endothelial functionS Kinlay, J Plutzky
Circulation|February 7, 2001
Statins for stroke: the second story?J Plutzky, P M Ridker
Journal of Cardiovascular Risk|September 12, 2001
Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?N Marx, P Libby, J Plutzky
Journal of Cardiovascular Risk|October 26, 1999
A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level loweringH Ginsberg, J Plutzky, B E Sobel
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Current Opinion in Lipidology|September 19, 2001
Peroxisome proliferator-activated receptors in endothelial cell biologyJ Plutzky
Current Opinion in Cardiology|February 24, 2001
Emerging concepts in metabolic abnormalities associated with coronary artery diseaseJ Plutzky
Current Atherosclerosis Reports|December 21, 2000
Peroxisome proliferator-activated receptors in vascular biology and atherosclerosis: emerging insights for evolving paradigmsJ Plutzky
The American Journal of Cardiology|November 6, 2001
Inflammatory pathways in atherosclerosis and acute coronary syndromesJ Plutzky
The American Journal of Medicine|August 1, 1990
On being a physicianJ Plutzky
The American Journal of Cardiology|July 27, 1999
Atherosclerotic plaque rupture: emerging insights and opportunitiesJ Plutzky
Current Cardiology Reports|September 12, 2000
Effect of lipid-lowering therapy on vasomotion and endothelial functionS Kinlay, J Plutzky
Circulation|February 7, 2001
Statins for stroke: the second story?J Plutzky, P M Ridker
Journal of Cardiovascular Risk|September 12, 2001
Peroxisome proliferator-activated receptors (PPARs) and their role in the vessel wall: possible mediators of cardiovascular risk?N Marx, P Libby, J Plutzky
Journal of Cardiovascular Risk|October 26, 1999
A review of metabolic and cardiovascular effects of oral antidiabetic agents: beyond glucose-level loweringH Ginsberg, J Plutzky, B E Sobel
Pageof 3